切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2018, Vol. 14 ›› Issue (02) : 193 -198. doi: 10.3877/cma.j.issn.1673-5250.2018.02.011

所属专题: 文献

论著

蜕膜组织种植建立子宫内膜异位症模型的可行性分析
曹杨1, 刘颖蕾1, 刘宏斌1, 周峰1, 乔海风1, 开海丽1, 刘曼华1,()   
  1. 1. 226001 江苏,南通大学第二附属医院妇产科
  • 收稿日期:2017-08-30 修回日期:2018-02-05 出版日期:2018-04-01
  • 通信作者: 刘曼华

Feasibility analysis of establishing endometriosis model by decidua tissue implantation

Yang Cao1, Yinglei Liu1, Hongbin Liu1, Feng Zhou1, Haifeng Qiao1, Haili Kai1, Manhua Liu1,()   

  1. 1. Department of Gynecology and Obstetrics, Second Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China
  • Received:2017-08-30 Revised:2018-02-05 Published:2018-04-01
  • Corresponding author: Manhua Liu
  • About author:
    Corresponding author: Liu Manhua, Email:
引用本文:

曹杨, 刘颖蕾, 刘宏斌, 周峰, 乔海风, 开海丽, 刘曼华. 蜕膜组织种植建立子宫内膜异位症模型的可行性分析[J]. 中华妇幼临床医学杂志(电子版), 2018, 14(02): 193-198.

Yang Cao, Yinglei Liu, Hongbin Liu, Feng Zhou, Haifeng Qiao, Haili Kai, Manhua Liu. Feasibility analysis of establishing endometriosis model by decidua tissue implantation[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2018, 14(02): 193-198.

目的

探讨蜕膜组织中胎盘生长因子(PLGF),雌激素受体(ER)-α、-β表达特性,为建立子宫内膜异位症(EMS)模型提供理论依据。

方法

选择2016年8月至2017年2月,于南通大学第二附属医院就诊的101例女性为研究对象。术中在无菌条件下,分别获取其中38例剖宫产术孕妇子宫内的蜕膜组织38例,37例EMS患者(其中31例合并子宫肌瘤)的在位内膜31例及异位内膜37例,26例子宫肌瘤患者的正常内膜26例。采用免疫组织化学和实时荧光定量聚合酶链反应(qPCR)技术,检测这4种子宫内膜组织中PLGF,ER-α、-β的阳性表达率及其mRNA相对表达量。对蜕膜组织中的PLGF, EF-α、-β与其他3种子宫内膜组织中的这3种因子阳性表达率及其mRNA相对表达量分别进行统计学比较。本研究所有受试者均知情同意。

结果

①免疫组织化学方法检测结果显示:蜕膜组织中PLGF,ER-α、-β的阳性表达率(86.8%、84.2%、78.9%),均分别高于在位内膜(61.3%、58.1%、38.7%)、异位内膜(54.1%、35.1%、48.6%)及正常内膜(57.7%、53.8%、38.5%),并且差异均有统计学意义(χ2=6.003、5.849、15.298;χ2=9.723、18.812、7.469;χ2=6.996、7.041、10.796;均为P<0.05)。②qPCR检测结果显示:蜕膜组织PLGF,ER-α、-β mRNA相对表达量[(2.60±0.26)、(2.22±0.23)、(2.05±0.31)],均分别高于在位内膜[(1.23±0.09)、(1.08±0.13)、(0.95±0.14)],异位内膜[(1.96±0.22)、(0.38±0.06)、(1.50±0.35)]及正常内膜[(1.00±0.13)、(1.00±0.11)、(1.00±0.14)],并且差异均有统计学意义(t=21.243、15.263、15.382;t=9.939、20.093、8.112;t=20.532、15.628、17.282;均为P<0.001)。

结论

蜕膜组织具有较强的种植特性,有助于形成子宫内膜异位病灶,是建立EMS模型的良好载体。

Objective

To explore the expression characteristics of placental growth factor (PLGF), estrogen receptor (ER) -α and ER-β in decidua tissue, and to provide a theoretical basis for the establishment of endometriosis (EMS) model.

Methods

From August 2016 to February 2017, a total of 101 women in Second Affiliated Hospital of Nantong University were selected as research subjects. Under the aseptic condition, a total of 38 cases of decidua tissue were obtained from 38 pregnant women of caesarean section, 31 cases of eutopic endometrium and 37 cases of ectopic endometrium were obtained from 37 cases of EMS patients (including 31 cases with hysteromyoma), and 26 cases of normal endometrium were obtained from 26 cases of hysteromyoma patients. Immunohistochemistry and quantitative real-time polymerase chain reaction (qPCR) were used to detect the positive expression rate and mRNA relative expression levels of PLGF, ER-α and ER-β in these 4 types of endometrium tissues. The positive expression rate and mRNA relative expression levels of 3 factors in decidua tissue were statistically compared with those in other 3 endometrial tissues, respectively. All subjects in this study signed informed consents.

Results

①The results of immunohistochemical staining showed that the positive expression rates of PLGF, ER-α and ER-β in decidua tissue (86.8%, 84.2%, 78.9%) were all higher than those in eutopic endometrium (61.3%, 58.1%, 38.7%), ectopic endometrium (54.1%, 35.1%, 48.6%) and normal endometrium (57.7%, 53.8%, 38.5%), respectively, and all the differences were statistically significant (χ2=6.003, 5.849, 15.298; χ2=9.723, 18.812, 7.469; χ2=6.996, 7.041, 10.796, all P<0.05). ②The results of qPCR detection showed that the mRNA relative expression levels of PLGF, ER-α and ER-β in decidual tissue [(2.60±0.26), (2.22±0.23), (2.05±0.31)], were all higher than those in eutopic endometrium [(1.23±0.09), (1.08±0.13), (0.95±0.14)], ectopic endometrium [(1.96±0.22), (0.38±0.06), (1.50±0.35)] and normal endometrium [(1.00±0.13), (1.00±0.11), (1.00±0.14)], respectively, and all the differences were statistically significant (t=21.243, 15.263, 15.382; t=9.939, 20.093, 8.112; t=20.532, 15.628, 17.282; all P<0.001).

Conclusions

Decidua tissue has strong planting characteristics which are helpful to the formation of ectopic lesions, and it provides a good carrier for the establishment of EMS model.

图2 4种子宫内膜组织中胎盘生长因子表达的免疫组织化学图(图2A:蜕膜组织中PLGF表达呈强阳性;图2B:在位内膜中PLGF表达呈弱阳性;图2C:异位内膜中PLGF表达呈阳性;图2D:正常内膜中PLGF表达呈弱阳性)(SP法)
表1 4种子宫内膜组织中3种因子阳性表达率比较[例数(%)]
图4 4种子宫内膜组织中雌激素受体-β表达的免疫组织化学图(图4A:蜕膜组织中ER-β表达呈强阳性;图4B:在位内膜中ER-β表达呈弱阳性;图4C:异位内膜中ER-β表达呈阳性;图4D:正常内膜中ER-β表达呈弱阳性)(SP法)
表2 4种子宫内膜组织中3种因子mRNA相对表达量比较(±s)
[1]
LiYZ,WangLJ,LiX, et al. Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and Meta-analysis of 14 case-control studies[J]. Genet Mol Res, 2013, 12(2): 1035-1044.
[2]
PellegriniC,GoriI,AchtariC, et al. The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis[J]. Fertil Steril, 2012, 98(5): 1200-1208.
[3]
SoysalD,Kizildag˘S,Saatli B, et al. A novel angiogenesis inhibitor bevacizumab induces apoptosis in the rat endometriosis model[J]. Balkan J Med Genet, 2014, 17(2): 73-80.
[4]
CosínR,Gilabert-EstellésJ,RamónLA, et al. Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis[J]. Hum Reprod, 2010, 25(2): 398-405.
[5]
FischerC,JonckxB,MazzoneM, et al. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels[J]. Cell, 2007, 131(3): 463-475.
[6]
SantiA,FelserRS,MuellerMD, et al. Increased endometrial placenta growth factor (PLGF) gene expression in women with successful implantation[J]. Fertil Steril, 2011, 96(3): 663-668.
[7]
王竹辉,何福仙. 胎盘生长因子(PLGF)及其受体血管内皮生长因子受体-1(VEGFR-1)在子宫内膜异位症中的表达及意义[J]. 中国优生与遗传杂志, 2006, 14(10): 17-18.
[8]
CosínR,Gilabert-EstellésJ,RamónLA, et al. Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression[J]. Fertil Steril, 2009, 92(4): 1214-1220.
[9]
BulunSE,ChengYH,PavoneME, et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis[J]. Semin Reprod Med, 2010, 28(1): 36-43.
[10]
FujimotoJ,HiroseR,SakaguchiH, et al. Expression of oestrogen receptor-alpha and-beta in ovarian endometriomata[J]. Mol Hum Reprod, 1999, 5(8): 742-747.
[11]
SmucT,PuceljMR,SinkovecJ, et al. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis[J]. Gynecol Endocrinol, 2007, 23(2): 105-111.
[12]
BukulmezO,HardyDB,CarrBR, et al. Inflammatory status influences aromatase and steroid receptor expression in endometriosis[J]. Endocrinology, 2008, 149(3): 1190-1204.
[13]
TrukhachevaE,LinZ,ReierstadS, et al. Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis[J]. J Clin Endocrinol Metab, 2009, 94(2): 615-622.
[1] 巨淑慧, 庞嘉越成, 皮浩, 蒋英杰, 李恒宇, 盛湲. ESR1基因突变在雌激素受体阳性转移性乳腺癌中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(01): 40-43.
[2] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[3] 林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[4] 罗丹, 孔为民, 陈姝宁, 赵小玲, 谢云凯. 子宫内膜异位症患者在位及异位内膜上皮细胞-间充质转化相关生物标志物的变化[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 530-539.
[5] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[6] 周东杰, 蒋敏, 范海瑞, 高玲玲, 孔祥, 卢丹, 王丽萍. 非编码RNA在卵泡发育成熟中作用及其机制的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 387-393.
[7] 陈荟竹, 郭应坤, 汪昕蓉, 宁刚, 陈锡建. 上皮性卵巢癌"二元论模型"的分子生物学研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 394-402.
[8] 韩春颖, 王婷婷, 李艳艳, 朴金霞. 子宫内膜癌患者淋巴管间隙浸润预测因素研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 403-409.
[9] 魏权, 张燊, 陈慧佳, 邹姮, 胡丽娜. 女性生殖道微生物群与辅助生殖技术相关性研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 151-155.
[10] 刘艳艳, 谭曦, 彭雪. 妊娠合并膀胱低度恶性潜能乳头状尿路上皮肿瘤并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 212-218.
[11] 胡欧婵, 黄仲英. 不明原因复发性流产患者的治疗研究现状与展望[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 16-22.
[12] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
[13] 吴晓翔, 杨波, 李景漩, 张凤玲, 郭桂辉, 郑少培. 脐动脉超声检查联合NLR、sFlt-1/PLGF对妊娠高血压综合征患者不良妊娠结局的预测价值[J]. 中华临床医师杂志(电子版), 2023, 17(03): 266-271.
[14] 王宁, 吴慢莉, 杨东霞. 代谢组学生物标志物:子宫内膜异位症诊疗的新靶点[J]. 中华临床医师杂志(电子版), 2022, 16(12): 1280-1283.
[15] 宋海红, 黎娉, 陈鲜霞. 子宫动脉搏动指数、外周血胎儿血红蛋白及胎盘生长因子水平与早发型子痫前期再次妊娠结局的关系[J]. 中华临床医师杂志(电子版), 2022, 16(11): 1109-1114.
阅读次数
全文


摘要